Home/Filings/4/0001384101-25-000031
4//SEC Filing

Stapley Marc 4

Accession 0001384101-25-000031

CIK 0001384101other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:41 PM ET

Size

8.6 KB

Accession

0001384101-25-000031

Insider Transaction Report

Form 4
Period: 2025-03-04
Stapley Marc
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-03-04$32.82/sh28,189$925,248292,543 total
  • Sale

    Common Stock

    2025-03-04$33.91/sh23,414$794,009269,129 total
  • Sale

    Common Stock

    2025-03-04$34.37/sh1,094$37,599268,035 total
Footnotes (4)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $32.27 to $33.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]Represents weighted average sales price. Sale prices for the transactions range from $33.28 to $34.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F4]Represents weighted average sales price. Sale prices for the transactions range from $34.29 to $34.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001539796

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:41 PM ET
Size
8.6 KB